These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10522669)

  • 21. Keratin expression in epidermolysis bullosa simplex (Dowling-Meara).
    Tidman MJ; Eady RA; Leigh IM; MacDonald DM
    Acta Derm Venereol; 1988; 68(1):15-20. PubMed ID: 2449006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Syndromes 13. Epidermolysis bullosa].
    Meijndert L; Jonkman MF
    Ned Tijdschr Tandheelkd; 1999 Aug; 106(8):302-5. PubMed ID: 11930425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrastructural differentiation of epidermolysis bullosa subtypes and porphyria cutanea tarda.
    Jaunzems AE; Woods AE
    Pathol Res Pract; 1997; 193(3):207-17. PubMed ID: 9198106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermolysis bullosa simplex (Dowling-Meara). A clinicopathological review.
    McGrath JA; Ishida-Yamamoto A; Tidman MJ; Heagerty AH; Schofield OM; Eady RA
    Br J Dermatol; 1992 May; 126(5):421-30. PubMed ID: 1610681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermolysis bullosa nevus arising in a patient with Dowling-Meara type epidermolysis bullosa simplex with a novel K5 mutation.
    Sugiyama-Fukamatsu H; Suzuki N; Nakanishi G; Iwatsuki K
    J Dermatol; 2009 Aug; 36(8):447-52. PubMed ID: 19691749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitrous oxide for procedural analgesia at home in a child with epidermolysis bullosa.
    Ingelmo P; Wei A; Rivera G
    Paediatr Anaesth; 2017 Jul; 27(7):776-778. PubMed ID: 28497520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue engineered skin: Apligraf, a bi-layered living skin equivalent.
    Trent JF; Kirsner RS
    Int J Clin Pract; 1998 Sep; 52(6):408-13. PubMed ID: 9894378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermolysis bullosa: new and emerging trends.
    Pai S; Marinkovich MP
    Am J Clin Dermatol; 2002; 3(6):371-80. PubMed ID: 12113646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dowling-Meara Epidermolysis bullosa herpetiformis].
    Mensing H; Heuer E; Schaeg G
    Monatsschr Kinderheilkd; 1986 Jul; 134(7):463-6. PubMed ID: 3748040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermolysis Bullosa: A Review of the Tissue-Engineered Skin Substitutes Used to Treat Wounds.
    du Rand A; Hunt JMT; Feisst V; Sheppard HM
    Mol Diagn Ther; 2022 Nov; 26(6):627-643. PubMed ID: 36251245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of skin substitutes in pediatric patients.
    Ozerdem OR; Wolfe SA; Marshall D
    J Craniofac Surg; 2003 Jul; 14(4):517-20. PubMed ID: 12867866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical treatment of recessive dystrophic epidermolysis bullosa in the hand: use of tissue-engineered skin (Apligraf).
    Phillips J; Rockwell WB
    Ann Plast Surg; 2003 Apr; 50(4):441-2. PubMed ID: 12671394
    [No Abstract]   [Full Text] [Related]  

  • 33. Epidermolysis bullosa: case report of appropriate classification of subtype because of an early dental exam.
    Bohaty B; Spencer P; Dunlap C; Wandera A
    J Clin Pediatr Dent; 1998; 22(3):243-5. PubMed ID: 9641100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Apligraf persistence and basement membrane restoration in donor site wounds: a pilot study.
    Hu S; Kirsner RS; Falanga V; Phillips T; Eaglstein WH
    Wound Repair Regen; 2006; 14(4):427-33. PubMed ID: 16939570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermolysis bullosa herpetiformis Dowling-Meara. Report of a case and pathomorphogenesis.
    Anton-Lamprecht I; Schnyder UW
    Dermatologica; 1982 Apr; 164(4):221-35. PubMed ID: 7084543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunofluorescence antigen mapping for hereditary epidermolysis bullosa.
    Rao R; Mellerio J; Bhogal BS; Groves R
    Indian J Dermatol Venereol Leprol; 2012; 78(6):692-7. PubMed ID: 23075637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using immunofluorescence (antigen) mapping in the diagnosis and classification of epidermolysis bullosa: a first report from Iran.
    Barzegar M; Asadi-Kani Z; Mozafari N; Vahidnezhad H; Kariminejad A; Toossi P
    Int J Dermatol; 2015 Oct; 54(10):e416-23. PubMed ID: 26220012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermolysis Bullosa (EB) Acquisita in an Adult Patient with Previously Unrecognized Mild Dystrophic EB and Biallelic COL7A1 Mutations.
    Guerra L; Condorelli AG; Fortugno P; Calabresi V; Pedicelli C; Di Zenzo G; Castiglia D
    Acta Derm Venereol; 2018 Apr; 98(4):411-415. PubMed ID: 29182795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laryngeal involvement in the Dowling-Meara variant of epidermolysis bullosa simplex with keratin mutations of severely disruptive potential.
    Shemanko CS; Horn HM; Keohane SG; Hepburn N; Kerr AI; Atherton DJ; Tidman MJ; Lane EB
    Br J Dermatol; 2000 Feb; 142(2):315-20. PubMed ID: 10730767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical management of epidermolysis bullosa: consensus clinical position statement from the European Reference Network for Rare Skin Diseases.
    Has C; El Hachem M; Bučková H; Fischer P; Friedová M; Greco C; Nevoránková P; Salavastru C; Mellerio JE; Zambruno G; Bodemer C
    J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):2349-2360. PubMed ID: 34545960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.